US Broker Ratings

Surgery Partners, Inc. (SGRY) Stock Analysis: Navigating a 42% Upside Potential in the Healthcare Sector

Surgery Partners, Inc. (NASDAQ: SGRY) is gaining attention in the healthcare sector, boasting a significant 42.02% potential upside based on analyst ratings. Headquartered in Brentwood, Tennessee,..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a 61% Potential Upside in the Biotech Sector

Investors with an eye on the healthcare sector should take a closer look at Immunovant, Inc. (NASDAQ: IMVT), a dynamic player in the biotechnology industry. Despite..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 47.51% Potential Upside in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL), a notable player in the healthcare sector, particularly within the biotechnology industry, is making waves with a promising potential upside of 47.51%...

HUTCHMED (China) Limited (HCM) Stock Analysis: 47% Upside Potential Amid Innovative Cancer Therapies

HUTCHMED (China) Limited (HCM), a Hong Kong-based pharmaceutical company, has garnered significant attention in the healthcare sector due to its innovative approach to targeted therapeutics and..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A 59.91% Potential Upside in the Biotech Sector

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a key player in the healthcare sector, specifically within the biotechnology industry, is capturing investor attention with its robust growth potential...

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Unveiling the Growth Potential in Spinal Surgery Technology

Alphatec Holdings, Inc. (ATEC), a prominent player in the medical devices industry, is making waves with its innovative approach to spinal disorder treatments. With a market..

Crinetics Pharmaceuticals (CRNX) Stock Analysis: 87% Upside Potential Sparks Investor Interest

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is capturing attention in the biotech investment community with its compelling growth prospects. With a market capitalization of $4.04 billion and..

Enovis Corporation (ENOV) Stock Analysis: Strong Buy Ratings and 58% Potential Upside

Enovis Corporation (ENOV), a prominent player in the healthcare sector, is carving a niche for itself within the medical devices industry. Headquartered in Wilmington, Delaware, this..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: A 44% Upside Potential with Strong Buy Ratings

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is catching the eye of investors with its robust performance in the healthcare sector, specifically within the drug manufacturing industry for..

Envista Holdings Corporation (NVST) Stock Analysis: Exploring a 9.51% Upside Potential

Envista Holdings Corporation (NYSE: NVST) presents an intriguing opportunity for investors keen on the healthcare sector, specifically within the medical instruments and supplies industry. With a..

ImmunityBio, Inc. (IBRX): An Investor Outlook on a Biotech Stock with 351% Potential Upside

ImmunityBio, Inc. (NASDAQ: IBRX), a prominent player in the biotechnology sector, stands out with an impressive potential upside of 351.33% according to current analyst ratings. The..

Denali Therapeutics (DNLI) Stock Analysis: Potential 106.6% Upside Amid Biotech Innovations

Denali Therapeutics Inc. (NASDAQ: DNLI) is capturing attention within the biotechnology sector, primarily due to its promising drug pipeline and the potential for significant stock price..

Addus HomeCare Corporation (ADUS) Stock Analysis: Exploring a 19.72% Potential Upside with Strong Buy Ratings

Addus HomeCare Corporation (NASDAQ: ADUS) is making waves in the healthcare sector, particularly within the Medical Care Facilities industry. With a market cap of $2.19 billion,..

Veracyte, Inc. (VCYT) Stock Analysis: Examining a 12.76% Upside Potential in the Healthcare Sector

Veracyte, Inc. (NASDAQ: VCYT), a key player in the diagnostics and research industry, is garnering attention from investors with its promising growth potential and a notable..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Potential 76% Upside Ignites Investor Interest

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a key player in the biotechnology sector, is capturing investor attention with a compelling potential upside of 76.07% based on its..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating Challenges with Diverse Rare Disease Portfolio

PTC Therapeutics, Inc. (PTCT), a pioneering player in the biotechnology sector, is known for its dedicated focus on the discovery, development, and commercialization of treatments for..

ACADIA Pharmaceuticals Inc. (ACAD): A Biotech Powerhouse with a 29.86% Potential Upside

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology sector, continues to capture investor attention with its robust focus on central nervous system (CNS)..

Viking Therapeutics, Inc. (VKTX)

⚠️ No article content returned.

..

Metsera, Inc. (MTSR) Stock Analysis: Understanding Its 6.14% Potential Downside Amidst Biotech Innovation

Metsera, Inc. (MTSR) is a burgeoning player in the healthcare sector, specifically within the biotechnology industry. Established in 2022 and headquartered in New York, this clinical-stage..

LivaNova PLC (LIVN) Stock Analysis: Navigating a 23.62% Potential Upside in the Healthcare Sector

LivaNova PLC (NASDAQ: LIVN) is emerging as a company of interest for investors in the healthcare sector, particularly in the medical devices industry. Based in the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds